Hedexin (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

The extract irritates the respiratory mucosa, which stimulates sensory nerves and increases bronchial secretions. The resulting rise in mucus volume and mild enhancement of ciliary activity facilitate the mobilization and expectoration of secretions, easing cough and improving airway patency.

The appropriate dose of Hedexin is determined by the prescribing healthcare professional based on the patient’s age, condition severity and overall health status. Patients should follow the specific instructions provided on the prescription label or by their clinician.

Safety data for Hedexin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the Hedexin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hedexin’s active ingredient, ivy leaf extract, offers a herbal alternative to synthetic expectorants such as guaifenesin. While both classes aim to increase mucus clearance, ivy leaf may provide additional anti‑inflammatory effects, though individual response and tolerability can vary.

Hedexin should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency.

Hedexin is taken orally, typically as a tablet, capsule or liquid preparation, as directed by a healthcare professional. The product should be swallowed with water and not chewed unless the formulation specifically advises otherwise.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, bronchospasm, and possible hepatic dysfunction. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or signs of liver injury.

Individuals with a known hypersensitivity to ivy (Hedera) or any component of the formulation should avoid Hedexin. Additionally, patients with uncontrolled asthma, severe liver disease, or those taking interacting medications should consult a clinician before use.